Nutex Health Files 8-K Under 'Other Events'

TL;DR

NUTX filed an 8-K for an 'Other Event' on 8/22. Details TBD.

AI Summary

Nutex Health, Inc. filed an 8-K on August 25, 2025, reporting an event on August 22, 2025. The filing is under 'Other Events' and does not provide specific details about the event itself within the provided text. The company, formerly known as Clinigence Holdings, Inc. and iGambit, Inc., is incorporated in Delaware and headquartered in Houston, Texas.

Why It Matters

This filing indicates a material event has occurred for Nutex Health, Inc., requiring disclosure to investors, though the specifics of the event are not detailed in this excerpt.

Risk Assessment

Risk Level: medium — The filing is an 8-K under 'Other Events', which suggests a significant development, but the lack of specific details in the provided text creates uncertainty.

Key Numbers

• 001-41346 — SEC File Number (Identifies the company's filing history with the SEC)
• 11-3363609 — IRS Employer Identification Number (Tax identification number for the company)

Key Players & Entities

• Nutex Health, Inc. (company) — Registrant
• Clinigence Holdings, Inc. (company) — Former company name
• iGambit, Inc. (company) — Former company name
• August 22, 2025 (date) — Earliest event date
• August 25, 2025 (date) — Filing date
• Houston, Texas (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value NUTX NASDAQ Capital Market

Filing Documents

• nutx-20250822.htm (8-K) — 22KB
• 0001479681-25-000070.txt ( ) — 137KB
• nutx-20250822.xsd (EX-101.SCH) — 2KB
• nutx-20250822_lab.xml (EX-101.LAB) — 22KB
• nutx-20250822_pre.xml (EX-101.PRE) — 13KB
• nutx-20250822_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. On August 22, 2025, a putative securities class action complaint was filed in the United States District Court for the Southern District of Texas in Harris County ( Anjana Bhagavan v. Nutex Health Inc ., Case No. 4:25-cv-03999). The complaint named Nutex Health Inc. (the "Company"), our Chairman of the Board and Chief Executive Officer, our Chief Financial Officer and our President and Director as defendants and asserted claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder. The allegations in the complaint track a recent short seller report. The plaintiff seeks unspecified damages. The Company disputes the allegations in the complaint and intends to vigorously defend the lawsuit. At this stage, the Company is unable to predict the outcome of the litigation or estimate the potential financial impact, but an adverse ruling could have a material adverse effect on the Company's financial position or results of operations.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company's intent to defend the lawsuit and its expectations regarding the potential impact of the litigation. Forward-looking statements are subject to risks and uncertainties that could cause actual outcomes to differ materially from those expressed or implied in the forward-looking statements, including risks related to litigation outcomes, legal costs, and the other factors described in the Company's periodic reports filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any forward-looking statement, except as required by law. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: August 25, 2025 Nutex Health Inc. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR